Contribute Try STAT+ Today

Despite a parade of studies warning that treatment guidelines issued by professional medical societies fail to fully disclose potential financial conflicts, two new analyses report that the problem persists.

In one analysis, researchers found that 57 percent of 91 authors who developed 18 different guidelines for several big-selling medicines had financial conflicts, and 25 percent of the authors did not disclose a conflict in the guidelines or supplemental materials. The median undisclosed payment was $522, while the average was $17,000. Moreover, none of the guidelines were fully compliant with disclosure requirements issued by the National Academy of Medicine.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.